Table 6.
Country | Reference | Source | Year(s) of survey | Ages surveyed (years) | Incidence (pmp) | Prevalence (pmp) | Survival (%) |
---|---|---|---|---|---|---|---|
Europe | |||||||
Denmark | ERA-EDTA [18] | Registry | 2012 | All | 107.5b | 461.6 | 1 yr (HD): 84.3e |
France | ERA-EDTA [18] | Registry | 2012 | All | 131.9b | 631.3 | — |
Germany | Frei et al. [31] | Survey | 2006 | All | — | 808 | — |
Greece | ERA-EDTA [18] | Registry | 2012 | All | 184.3b | 904.4 | 1 yr (HD): 84.3e |
Italy | ERA-EDTA [18] | Registry | 2010 | All | — | 756.4 | 1 yr (HD): 84.3e |
Portugal | ERA-EDTA [18] | Registry | 2012 | All | 205.5b | 1067.9 | — |
Russian Federation | ERA-EDTA [18] | Registry | 2011 | All | — | 170.0 | — |
Spain | ERA-EDTA [18] | Registry | 2012 | All | 87.9–127.2bd | 537.54 | 1 yr (HD): 84.3e |
Sweden | ERA-EDTA [18] | Registry | 2012 | All | 93.4b | 403.0 | 1 yr (HD): 84.3e |
Netherlands | ERA-EDTA [18] | Registry | 2012 | All | 98b | 384.3 | 1 yr (HD): 84.3e |
United Kingdom | UKRR [19] | Registry | 2012 | ≥20 | 91.0b | 432.5 | 1 yr: 96.1 |
Asia | |||||||
China | Zuo et al. [30] | Survey | 2008 | All | — | 79.1 | — |
India | — | — | — | — | — | — | — |
Hong Kong | Ho et al. [28] | Registry | 1995–2011 | All | — | 677.6 | 1 yr (HD): 83.9 1 yr (PD): 91.1 5 yr (HD): 55.7 5 yr (PD): 50.7 |
Japan | JSDT [20] | Survey | 2011 | All | — | 2385.4 | 1 yr: 87.7 |
Republic of Korea | Korean ESRD Registry [35] | Registry | 2013 | All | 200.3 | 1154.9 | 1 yr (HD): 94.9 1 yr (PD): 95.5 5 yr (HD): 73.7 5 yr (PD): 68.4 |
Turkey | ERA-EDTA [18] | Registry | 2012 | All | 208.9b | 919 | 5 yr (HD): 60.4f
5 yr (PD): 80.6 f |
Oceania | |||||||
Australia | ANZDATA [26] | Registry | 2012 | All | — | 507 | 1 yr: 86h
5 yr: 42h |
The Americas | |||||||
Brazil | Neil et al. [5] | Survey | 2011 | All | 149 | 475 | 5 yr (HD): 58.2g |
Canada | CORR [24] | Registry | 2012 | All | 150.4 | 682.8 | 1yr: 84.3 5yr: 43.8 |
Mexico | Rosa-Diez et al. [27] | Registry | 2010 | All | — | 866.9 | |
United States | USRDS [25] | Registry | 2011 | All | 348.8c | 1321.3c | 1 yr: 76.0c
5 yr: 36.0c |
—: data not available.
ANZDATA: The Australia and New Zealand Dialysis and Transplant Registry; CORR: Canadian Organ Replacement Register; ERA-EDTA: European Renal Association-European Dialysis and Transplant Association; HD: hemodialysis; JSDT: Japanese Society for Dialysis Therapy; LADTR: Latin American Dialysis and Transplant Registry; PD: peritoneal dialysis; UKRR: UK Renal Registry; USRDS: United States Renal Data System.
aHemodialysis/hemofiltration and peritoneal dialysis modes.
bIncidence at day 91.
cEstimate adjusted for modality, age, gender race, ethnicity, and primary diagnosis.
dEstimate varies by region.
eSurvival estimate is a combined multination estimate from ERA-EDTA; survival from day 91 forward.
fEstimate is from the Registry of the Nephrology, Dialysis and Transplantation in Turkey (2007).
gEstimate is from the Latin American Fresenius Medical Care Database.
Survival data is stratified by age; 1-year and 5-year survival information provided is for the 65–74 yr age group of Australians.